GRL-079, a novel P2-Tp-THF-C5-alkylamine- and P2' -Abt-containing HIV-1 protease inhibitor, is extremely potent against multi-drug-resistant HIV-1 variants including HIVDRVRp51 and has a high genetic barrier against the emergence of resistant varian
about
GRL-079, a novel P2-Tp-THF-C5-alkylamine- and P2' -Abt-containing HIV-1 protease inhibitor, is extremely potent against multi-drug-resistant HIV-1 variants including HIVDRVRp51 and has a high genetic barrier against the emergence of resistant varian
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
GRL-079, a novel P2-Tp-THF-C5- ...... emergence of resistant varian
@en
GRL-079, a novel P2-Tp-THF-C5- ...... emergence of resistant varian
@nl
type
label
GRL-079, a novel P2-Tp-THF-C5- ...... emergence of resistant varian
@en
GRL-079, a novel P2-Tp-THF-C5- ...... emergence of resistant varian
@nl
prefLabel
GRL-079, a novel P2-Tp-THF-C5- ...... emergence of resistant varian
@en
GRL-079, a novel P2-Tp-THF-C5- ...... emergence of resistant varian
@nl
P2093
P2860
P356
P1476
GRL-079, a Novel HIV-1 Proteas ...... mergence of Resistant Variants
@en
P2093
Arun K Ghosh
Cuthbert D Martyr
Debananda Das
Hiroaki Mitsuya
Hironori Hayashi
Manabu Aoki
Nicole S Delino
Shin-Ichiro Hattori
Simon B Chang
P2860
P356
10.1128/AAC.02060-17
P407
P577
2018-04-26T00:00:00Z